Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Favrille raises $21.1 million

FVRL raised $21.1 million in a registered direct offering

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE